Anagenics Limited
AN1.ASXConsumer Staples
Health and beauty-tech business.
Market Data
$0.007
-0.1%$6.9M
-100000.0x
$-0.001
0.00%
+0.1%
Latest Earnings
Appendix 4D 1H FY26 DEC 2025
25 February 2026
Anagenics Limited achieved a significant turnaround in 1H FY26, delivering its maiden profit of $127k compared to a $464k loss in the prior period, despite revenue declining 10% to $2.64M. The company's restructure successfully improved gross profit margins by 280 basis points and reduced operating expenses by 44%. This represents a material operational improvement following the company's strategic restructuring. Key points: Achieved maiden profit of $127k compared to $464k loss in prior period; Gross profit margin improved by 280 basis points following restructure; Operating expenses reduced by 44% through successful cost management
Recent Announcements
Appendix 4D 1H FY26 DEC 2025
Anagenics Limited achieved a significant turnaround in 1H FY26, delivering its maiden profit of $127k compared to a $464k loss in the prior period, despite revenue declining 10% to $2.64M. The company's restructure successfully improved gross profit margins by 280 basis points and reduced operating expenses by 44%. This represents a material operational improvement following the company's strategic restructuring. Key points: Achieved maiden profit of $127k compared to $464k loss in prior period; Gross profit margin improved by 280 basis points following restructure; Operating expenses reduced by 44% through successful cost management
Becoming a substantial holder
David Dominic Pevcic became a substantial holder (5.52%).
Becoming a substantial holder
Sufian Ahmad became a substantial holder (6.62%).
Get real-time alerts for AN1
Receive AI-powered earnings summaries and instant notifications when Anagenics Limited releases results.
Register Free